Tibet Rhodiola Pharmaceutical Holding Co. Announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 296.779 million compared to CNY 297.076 million a year ago. Operating income was CNY 144.765 million compared to CNY 79.734 million a year ago. Net income was CNY 128.531 million compared to CNY 70.717 million a year ago. Basic earnings per share from continuing operations was CNY 0.73 compared to CNY 0.39 a year ago.